Combination therapy for treating drug-resistance cancer using Rifabutin
The present invention relates to an anticancer adjuvant containing rifabutin as an active ingredient, which is a novel anticancer adjuvant which can be administered in combination with anticancer drugs to resistant cancer cells overexpressing P-glycoprotein (P-gp), which can excrete an anticancer ag...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; kor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!